P967: A MACHINE LEARNING MODEL FOR RISK PREDICTION IN MULTIPLE MYELOMA PROGRESSING AFTER THE FIRST LINE OF THERAPY

P967: A MACHINE LEARNING MODEL FOR RISK PREDICTION IN MULTIPLE MYELOMA PROGRESSING AFTER THE FIRST LINE OF THERAPY

Bibliographic Details
Main Authors:	Adrian Mosquera-Orgueira, Marta Sonia Gonzalez Perez, Jose Angel Diaz Arias, Maria-Victoria Mateos
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000970772.58012.ca

Similar Items

Prognostic Stratification of Multiple Myeloma Using Clinicogenomic Models: Validation and Performance Analysis of the IAC-50 Model
by: Adrián Mosquera Orgueira, et al.
Published: (2022-08-01)

How artificial intelligence revolutionizes the world of multiple myeloma
by: Martha Romero, et al.
Published: (2024-02-01)

Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group
by: Adrian Mosquera Orgueira, et al.
Published: (2022-04-01)

De novo drug design through artificial intelligence: an introduction
by: Davide Crucitti, et al.
Published: (2024-01-01)

Efficacy of Bortezomib as First-Line Treatment for Patients with Multiple Myeloma
by: Utkarsh Painuly, et al.
Published: (2013-02-01)

Efficacy of Bortezomib as First-Line Treatment for Patients with Multiple Myeloma
by: Utkarsh Painuly, et al.
Published: (2013-01-01)

Conflict and war in the Middle East, l967-91 : regional dynamic and the superpowers /
by: 201426 Tibi, Bassam, et al.
Published: (1993)

Hidden among the crowd: differential DNA methylation-expression correlations in cancer occur at important oncogenic pathways
by: Adrián Mosquera Orgueira
Published: (2015-05-01)

Bone healing in multiple myeloma: a prospective evaluation of the impact of first-line anti-myeloma treatment
by: Maja Hinge, et al.
Published: (2016-10-01)

P967: TUMOR BURDEN AS A CRITICAL PROGNOSTIC FACTOR OF PRIMARY EXTRAMEDULLARY DISEASE
by: M. Vlachová, et al.
Published: (2022-06-01)

Smoldering multiple myeloma current treatment algorithms
by: S. Vincent Rajkumar, et al.
Published: (2022-09-01)

Can multiple myeloma become a curable disease?
by: Jesús F. San-Miguel, et al.
Published: (2011-09-01)

Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy
by: Noopur Raje, et al.
Published: (2023-03-01)

Front-line treatment of multiple myeloma
by: Michele Cavo, et al.
Published: (2019-06-01)

Correction: Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy
by: Noopur Raje, et al.
Published: (2023-07-01)

The Impact of Modern Bone Markers in Multiple Myeloma: Prospective Analyses Pre and Post-First Line Treatment
by: Vlad Stefan Pop, et al.
Published: (2024-08-01)

RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE CURRENT STATE OF PLAY
by: María-Victoria Mateos, et al.
Published: (2015-07-01)

11.967 Special Studies in Urban Studies: Economic Development Planning Skills, January (IAP) 2003
by: Seidman, Karl F.
Published: (2003)

Mass Spectrometry as Alternative Method to Identify and Monitor Non-Secretory Progressive Disease in Patients with Multiple Myeloma
by: Cristina Agulló, et al.
Published: (2024-05-01)

Time to Treatment Prediction in Chronic Lymphocytic Leukemia Based on New Transcriptional Patterns
by: Adrián Mosquera Orgueira, et al.
Published: (2019-02-01)

Genomic patterns of progression in smoldering multiple myeloma
by: Bolli, N, et al.
Published: (2018)

CYTOKINE REGULATION IN THE COURSE OF MULTIPLE MYELOMA PROGRESSION
by: O. V. Smirnova, et al.
Published: (2015-06-01)

The Role of Epigenetics in the Development and Progression of Multiple Myeloma
by: Nor Hayati Ismail, et al.
Published: (2022-10-01)

Research Progress of Immune Microenvironment in Multiple Myeloma
by: HOU Jian, et al.
Published: (2022-05-01)

Effectiveness of first line treatment with bortezomib prior to autologous stem cell transplantation for multiple myeloma
by: Peter Černelč, et al.
Published: (2012-04-01)

Anti-BCMA CAR T-cell Therapy: Changing the Natural History of Multiple Myeloma
by: Borja Puertas, et al.
Published: (2022-03-01)

Corrigendum to “Nucleon-nucleon potential from skyrmion dipole interactions” [Nucl. Phys. B 967 (2021) 115430]
by: Derek Harland, et al.
Published: (2022-12-01)

Pulmonary Embolism as the First Manifestation of Multiple Myeloma
by: N. Vallianou, et al.
Published: (2013-01-01)

Maxillary Swelling as the First Evidence of Multiple Myeloma
by: Atsushi Kasamatsu, et al.
Published: (2015-01-01)

Mandibular Swelling as the First Manifestation of Multiple Myeloma
by: Maryam Amirchaghmaghi, et al.
Published: (2010-12-01)

Bacterial meningitis as the first presentation of multiple myeloma
by: Sasmita Zutushi, et al.
Published: (2022-01-01)

First-Line Combination with Proteasome Inhibitor-Based Treatment and Zoledronic Acid Is Effective in Reducing Later Fractures in Multiple Myeloma Irrespective of Multiple Myeloma Bone Disease at Diagnosis
by: Veera Eskelinen, et al.
Published: (2024-08-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma
by: Francesca Bonello, et al.
Published: (2020-12-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

Internationalization Of The Housing Development Sector: A Study Of The Malaysian Scenario [HD7287. A967 2007 f rb].
by: Awil, Ahmed Usman
Published: (2007)

Highly Oxygenated Constituents from a Marine Alga-Derived Fungus <i>Aspergillus giganteus</i> NTU967
by: Jih-Jung Chen, et al.
Published: (2020-06-01)

DUPLICITY AND EVOLUTION STATUS OF THE EARLY-TYPE Be STAR V622Per, THE MEMBER OF THE χ Per OPEN STAR CLUSTER
by: S. L. Malchenko, et al.
Published: (2007-12-01)

Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy
by: Raphael Lutz, et al.
Published: (2024-11-01)

Monoclonal Gammopathy of Renal Significance with Progression to Multiple Myeloma in a Patient with ASIA-MO Syndrome
by: David Alejandro Vargas Gutiérrez, et al.
Published: (2022-01-01)